Your path to Ultra-Wealth with BTIM part 2 

Jan 2, 2010 

Fellow long time Friends and Supporters

    Sorry for the repeat of this 1st part. 

    I will attempt to give you a brief glimpse into one of the greatest investment opportunities I have ever seen in my 49 year career. 

     If you only believe only a fraction of what Dr, West said in his Annual  Meeting address(see video @ www.biotimeinc.com )  given to stockholders you could be on your way to Ultra-Wealth by investing in Biotime(BTIM). Here we are talking about a cure for cancer, reversing aging,restoring youth and lengthening lives or a proverbial fountain of youth etc.  

     Before I hit a few high notes let me take you back a few years ago when I first started to talk to a few of you about BTIM. Back in 2007 BTIM had less than 7 employees no analyst coverage,listed on the bulletin board,trading around $.30-$.40 a share with no real business as The Bush stopped funding Stem Cell research. BTIM had an approved Blood expander Hextend but the product has not reached profitability yet. 

      Dr. West BTIM's CEO was considered a pioneer in the STEM Cell space.. He was the founder of the first 2 real Stem Cell companies out there They were Geron and Advanced Cell Technology(ACT). Geron has been out there for 12 years with no approved products. ACT had a fortune in patents and patent applications but no money to exploit their potential. ACT was trading for pennies a share. 

      Then in August 2008 BTIM announced it had acquired ACT's portfolio of patents and patent applications that will be used for the commercialization of products in human therapeutic and diagnostic products markets. Today I hear that estimates that the value of these patents could be worth north of $200 million. BTIM paid only $1 million plus some royalties. BTIM has never traded below a $1.25 since  A new Stem Cell Patent Leader emerges and some of you already own it. 

     Most of all I like what I see and hear about BTIM going forward.with a rather unique business plan. BTIM forms a new company Oncyte Technologies for curing cancer. An outside Investor puts $2 million in for 15-20% of the company. Some where down the road when this company is ready BTIM will  spin it off to shareholders to give us a pure play on the patent or application. BTIM has formed another with more to follow,any one of which could be worth $ billions with a successful product. There are over 200 patentable products in BTIM with more coming all the time. 

    As an added bonus and for your information Big Pharma is out there on the prowl with $ billions to spend on these new technologies. Just think what it will mean to BTIM shareholders with 100's of little BTIM's out there waiting to be acquired or get a infusion of cash with royalties to follow  down the road. I alerted you just a few weeks ago on a small $6 million ATHX deal which more than tripled its the market cap overnight to $150 million. 

     There is a major deal in China to fund BTIM's research and development you can also read about on the web. This is ground breaking in size and scope for such a small company. BTIM will be able to get products to world markets in a much shorter time span then going through our FDA. People around the world are already using the technology I'm told. Ask yourself what will people pay to be younger, have a new heart, walk or see again etc.with no rejection. 

    On April 27,2009 President Obama pledged to spend a full 3% of the U.S.'s GDP or over $415 billion on science and innovation to keep the U.S. a technology leader. Go Obama!!!. Just recently the National Institute of Health(NIH) released 100's of approved Stem Cells for study. It's no longer when this will happen, it's already here. 

 

 

Disclaimer: Please read and remember YOU are responsible!

All information contained within the website www.RobinDayne.com (RDI) by Robin Dayne Inc is made available solely for Educational Purposes Only, including but not limited to, information presented by Robin Dayne, Robin Dayne, Inc., or any instructors who may provide information for the RDI site from time to time. Additionally, Robin Dayne Inc. maintains no responsibility for verifying any statements made by visitors to the RDI website, nor will any such statements be edited for content. RDI makes no warranties or representations as to the RDI content and assumes no liability or responsibility for any errors or omissions therein. By agreeing below, you understand that you alone assume all risks associated with implementing any strategies discussed in the RDI website and that you alone are responsible for any and all trading activities you engage in the future, including any losses and/or profits that may result there from. You further understand that the information contained in this RDI website is not meant to be advice and should not be construed as advice from RDI or any party who may be posted within the website from time to time.

Copyright and duplication in any form of media is strictly prohibited without written permission from RDI Copyright © 2007-2010